Stock listing
NASDAQ:VRDN Viridian Therapeutics, Inc. Stock
Home listing (NASDAQ) of Viridian Therapeutics, Inc.
Follow Viridian Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VRDN
$28.49 USD -0.06 (-0.2%)
Close on Nov 6, 2026
- Day range
- $27.86 – $29.46 USDNov 6, 2026
- Volume
- 4.48M sharesNov 6, 2026
- Market cap
- $3.23B USDAt the close on Nov 6, 2026 · price × 113.3M shares outstanding
- 52-week range
- $13.18 – $34.29 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $47.35M USDMedian day 1.70M shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VRDN · Home | $28.49 USD | -0.06 (-0.2%) | 4,475,176 | $28.66 | $29.46 | $27.86 | $28.55 | Close on Nov 6, 2026 |
| LSE:0K1R | $29.03 USD | +0.252 (+0.9%) | 1,174 | $28.20 | $29.48 | $27.86 | $28.78 | Close on Nov 6, 2026 |
| Frankfurt:1S1 | €25.40 EUR | -0.80 (-3.1%) | — | €25.40 | €25.40 | €25.40 | €26.20 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:VRDN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $28.49 | -0.06 | -0.2% | $28.66 | $29.46 | $27.86 | 4,475,176 | |
| $28.55 | -0.505 | -1.7% | $29.58 | $29.61 | $28.48 | 3,433,450 | |
| $29.06 | +3.905 | +15.5% | $28.27 | $29.74 | $25.07 | 11,158,461 | |
| $25.15 | -0.15 | -0.6% | $25.61 | $26.21 | $24.52 | 4,062,896 | |
| $25.30 | +0.63 | +2.6% | $24.78 | $25.58 | $23.97 | 3,391,258 | |
| $24.67 | -0.13 | -0.5% | $24.77 | $25.00 | $24.14 | 1,710,583 | |
| $24.80 | +0.53 | +2.2% | $24.35 | $25.32 | $24.23 | 1,905,012 | |
| $24.27 | +0.18 | +0.7% | $23.72 | $24.42 | $23.66 | 1,412,513 | |
| $24.09 | +0.75 | +3.2% | $23.29 | $24.12 | $23.19 | 2,808,240 | |
| $23.34 | +0.97 | +4.3% | $22.50 | $23.35 | $22.33 | 1,515,412 | |
| $22.37 | -0.45 | -2.0% | $22.75 | $22.75 | $21.92 | 1,175,800 | |
| $22.82 | -0.19 | -0.8% | $23.00 | $23.59 | $22.66 | 1,545,900 | |
| $23.01 | +0.58 | +2.6% | $22.50 | $23.29 | $22.47 | 1,921,000 | |
| $22.43 | +1.63 | +7.8% | $21.10 | $22.68 | $20.85 | 1,974,600 | |
| $20.80 | +1.77 | +9.3% | $19.23 | $20.88 | $19.07 | 2,576,100 | |
| $19.03 | -0.53 | -2.7% | $19.67 | $19.78 | $18.94 | 2,457,300 | |
| $19.56 | +1.18 | +6.4% | $18.69 | $19.78 | $18.54 | 2,167,900 | |
| $18.38 | +0.16 | +0.9% | $18.19 | $18.75 | $18.01 | 3,732,900 | |
| $18.22 | -0.08 | -0.4% | $18.04 | $18.33 | $17.96 | 2,124,100 | |
| $18.30 | -0.36 | -1.9% | $19.00 | $19.19 | $18.21 | 1,946,500 | |
| $18.66 | +0.32 | +1.7% | $18.31 | $18.72 | $18.16 | 1,334,200 | |
| $18.34 | +0.06 | +0.3% | $18.02 | $18.44 | $17.59 | 2,443,800 | |
| $18.28 | +0.06 | +0.3% | $18.02 | $18.73 | $17.92 | 1,691,100 | |
| $18.22 | -0.78 | -4.1% | $19.00 | $19.13 | $18.07 | 2,195,800 | |
| $19.00 | -0.40 | -2.1% | $19.41 | $19.59 | $18.83 | 2,651,200 | |
| $19.40 | +0.41 | +2.2% | $19.16 | $19.55 | $18.92 | 1,515,400 | |
| $18.99 | -1.60 | -7.8% | $20.61 | $20.61 | $18.99 | 3,375,300 | |
| $20.59 | +0.595 | +3.0% | $20.27 | $20.75 | $20.00 | 1,404,800 | |
| $20.00 | -0.575 | -2.8% | $20.69 | $20.85 | $19.73 | 1,233,600 | |
| $20.57 | +0.10 | +0.5% | $20.31 | $20.71 | $20.03 | 1,339,100 | |
| $20.47 | -0.19 | -0.9% | $20.75 | $21.01 | $20.16 | 2,090,600 | |
| $20.66 | -0.77 | -3.6% | $21.10 | $21.25 | $20.22 | 2,211,300 | |
| $21.43 | -0.69 | -3.1% | $22.11 | $22.19 | $21.20 | 2,857,600 | |
| $22.12 | +0.54 | +2.5% | $22.02 | $22.33 | $21.54 | 1,456,700 | |
| $21.58 | -0.42 | -1.9% | $22.28 | $22.40 | $21.53 | 1,745,400 | |
| $22.00 | +0.07 | +0.3% | $21.99 | $22.17 | $21.80 | 5,381,500 | |
| $21.93 | -0.51 | -2.3% | $22.88 | $22.97 | $21.72 | 1,268,400 | |
| $22.44 | +0.61 | +2.8% | $21.89 | $22.46 | $21.68 | 1,671,900 | |
| $21.83 | -0.37 | -1.7% | $21.98 | $22.14 | $21.40 | 1,210,900 | |
| $22.20 | +0.96 | +4.5% | $21.47 | $22.30 | $21.27 | 1,300,800 | |
| $21.24 | -1.05 | -4.7% | $22.48 | $22.70 | $21.19 | 943,200 | |
| $22.29 | -0.44 | -1.9% | $22.40 | $22.60 | $21.99 | 1,310,100 | |
| $22.73 | -0.44 | -1.9% | $23.11 | $23.58 | $22.70 | 1,578,300 | |
| $23.17 | +0.25 | +1.1% | $22.38 | $23.84 | $22.22 | 1,829,300 | |
| $22.92 | -0.04 | -0.2% | $22.62 | $23.03 | $22.62 | 759,900 | |
| $22.96 | +0.18 | +0.8% | $23.08 | $23.28 | $22.57 | 1,193,800 | |
| $22.78 | -0.25 | -1.1% | $23.11 | $23.74 | $22.39 | 1,417,400 | |
| $23.03 | -0.13 | -0.6% | $23.02 | $23.34 | $22.89 | 998,400 | |
| $23.16 | +0.08 | +0.3% | $22.94 | $23.27 | $22.62 | 1,048,800 | |
| $23.08 | -0.80 | -3.4% | $23.58 | $23.70 | $23.04 | 778,900 | |
| $23.88 | -0.38 | -1.6% | $24.22 | $24.47 | $23.75 | 839,700 | |
| $24.26 | +0.08 | +0.3% | $24.16 | $24.46 | $23.92 | 780,800 | |
| $24.18 | +0.16 | +0.7% | $24.30 | $24.80 | $24.08 | 901,400 | |
| $24.02 | -0.27 | -1.1% | $24.35 | $24.39 | $24.00 | 1,131,100 | |
| $24.29 | -0.21 | -0.9% | $24.65 | $24.75 | $24.07 | 905,600 | |
| $24.50 | -0.30 | -1.2% | $24.61 | $24.72 | $23.96 | 1,076,000 | |
| $24.80 | +0.87 | +3.6% | $24.52 | $24.86 | $23.80 | 1,833,800 | |
| $23.93 | +0.84 | +3.6% | $23.00 | $23.95 | $22.84 | 1,992,400 | |
| $23.09 | +1.01 | +4.6% | $21.92 | $23.29 | $21.87 | 1,892,800 | |
| $22.08 | +0.09 | +0.4% | $22.00 | $22.23 | $21.62 | 1,093,300 | |
| $21.99 | -0.89 | -3.9% | $22.70 | $22.86 | $21.89 | 1,767,600 | |
| $22.88 | -0.09 | -0.4% | $23.16 | $23.60 | $22.72 | 1,578,300 | |
| $22.97 | -0.09 | -0.4% | $23.23 | $23.83 | $22.81 | 3,063,000 | |
| $23.06 | -0.53 | -2.2% | $23.46 | $23.57 | $22.78 | 2,268,300 | |
| $23.59 | +1.08 | +4.8% | $22.98 | $23.61 | $22.53 | 1,659,800 | |
| $22.51 | +1.44 | +6.8% | $20.94 | $22.52 | $20.53 | 4,289,600 |
- Ticker
- NASDAQ:VRDN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Viridian Therapeutics to Host Conference Call to Present VRDN-008 Phase 1 Data and FcRn Portfolio Plans on November 9, 2026
Latest earnings call · Nov 4, 2026
Viridian Therapeutics (NASDAQ:VRDN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 4, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Calls
Replays
Viridian Therapeutics (NASDAQ:VRDN) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 8:00 AM ET
Watch TranscriptViridian Therapeutics (NASDAQ:VRDN) Q4 2024 Earnings Call
Wed, Mar 12, 2025 · 10:00 AM ET
Watch TranscriptViridian Therapeutics (NASDAQ:VRDN) Q1 2024 Earnings Call
Wed, May 08, 2024 · 8:00 AM ET
Watch Transcript
Latest news
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
Nov 4, 2026
Closed $29.06 (+15.5%) on Nov 4, 2026
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
Oct 20, 2026
Closed $23.01 (+2.6%) on Oct 21, 2026
Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
Sep 2, 2026
Closed $22.96 (+0.8%) on Sep 3, 2026
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $22.51 (+6.8%) on Aug 6, 2026
Raymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)
Jul 16, 2026
Closed $18.03 (-5.4%) on Jul 16, 2026
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa(TM) (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
Jun 26, 2026
Closed $18.79 (+5.0%) on Jun 29, 2026
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
Jun 26, 2026
Closed $18.79 (+5.0%) on Jun 29, 2026
Financings
Public offering of shares of common stock and Series B non-voting convertible preferred stock
Oct 21, 2025
Announced: about US$251.35M · US$22 a share · Jefferies +4
Dealers: Jefferies (co-lead), Leerink Partners (co-lead), Evercore ISI (co-lead), Stifel (co-lead), Wedbush PacGrow
Use of proceeds: Commercial launch of veligrotug and VRDN-003, research and development, working capital and general corporate purposes
Royalty financing on U.S. net sales
Oct 20, 2025
Announced: up to US$300M · Goldman Sachs & Co. LLC
Dealers: Goldman Sachs & Co. LLC
Buyers: DRI Healthcare Acquisitions LP (Royalty financing of up to $300 million, including $55 million upfront and $115 million in potential near-term milestones)
Use of proceeds: Fund the anticipated commercial launches of veligrotug and VRDN-003
Decks
Q3 2026 Earnings Presentation
Earnings · 15 slides · Nov 4, 2026
Corporate Update (June 2026)
Corporate update · 28 slides · Jun 29, 2026
Technical Presentation (May 2026)
Technical · 20 slides · May 5, 2026
Investor Presentation (May 2026)
Investor deck · 71 slides · May 5, 2026
Viridian Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 157 in all · newest Nov 6, 2026 · oldest 2019
- Calls
- 7 calls with a replay · 7 with a transcript · latest Nov 4, 2026
- Decks
- 24 decks · latest Nov 4, 2026
Where Viridian Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VRDN · Home listing · This page | NASDAQ | United States | USD |
| gettex:1S1 | gettex | Germany | EUR |
| LS Exchange:A2QMUH | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2QMUH | Lang & Schwarz | Germany | EUR |
| LSE:0K1R | LSE | United Kingdom | USD |
| Tradegate:1S1 | Tradegate | Germany | EUR |
| BOATS:VRDN | BOATS | United States | USD |
| Frankfurt:1S1 | Frankfurt | Germany | EUR |
| Dusseldorf:1S1 | Dusseldorf | Germany | EUR |
| Stuttgart:1S1 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Viridian Therapeutics, Inc.